Cost-Effective Components of a Patient-Reported Symptom Monitoring System for Chemotherapy
This cost-effectiveness study of ePRO symptom management components found that the complete SCH intervention with all component parts was the most cost-effective treatment strategy. From a value-driven perspective, comprehensive ePRO systems both improve quality through reduced symptom burden and were most cost-effective.
Authors
- Natalya Alekhina (ORCID: https://orcid.org/0000-0001-6181-2975)
- Kathi Mooney (ORCID: https://orcid.org/0000-0003-3371-5646)
- Elizabeth A. Sloss (ORCID: https://orcid.org/0000-0003-2071-5495)
- Minkyoung Yoo (ORCID: https://orcid.org/0000-0002-9765-1197)
- Richard E. Nelson (ORCID: https://orcid.org/0000-0002-4441-7460)
- Eli Iacob (ORCID: https://orcid.org/0000-0003-1617-0314)
- Bridget Nicholson (ORCID: https://orcid.org/0009-0001-4709-4695)
Institutions
- University of Utah (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-11-10
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.42289
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Veterans Affairs
- National Institutes of Health
- National Cancer Institute